Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (51511) 51511
Newspaper Article (13615) 13615
Newsletter (10288) 10288
Book Review (8089) 8089
Publication (3628) 3628
Magazine Article (1633) 1633
Trade Publication Article (735) 735
Web Resource (691) 691
Book Chapter (484) 484
Conference Proceeding (406) 406
Book / eBook (134) 134
Reference (132) 132
Transcript (122) 122
Dissertation (106) 106
Report (23) 23
Government Document (13) 13
Paper (10) 10
Streaming Video (10) 10
Data Set (5) 5
Video Recording (4) 4
Journal / eJournal (1) 1
Microfilm (1) 1
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
antidepressants (58324) 58324
index medicus (34067) 34067
humans (24465) 24465
male (18553) 18553
psychiatry (16483) 16483
female (14244) 14244
depression, mental (13814) 13814
depression (12581) 12581
pharmacology & pharmacy (12134) 12134
neurosciences (11260) 11260
animals (11254) 11254
drug therapy (10845) 10845
adult (10054) 10054
research (9845) 9845
mental depression (8668) 8668
middle aged (8530) 8530
antidepressive agents - therapeutic use (8215) 8215
drugs (8152) 8152
antidepressant (7475) 7475
analysis (6480) 6480
serotonin (6322) 6322
rats (6191) 6191
clinical neurology (6055) 6055
major depression (5840) 5840
aged (5592) 5592
care and treatment (5559) 5559
major depressive disorder (4872) 4872
treatment outcome (4716) 4716
reports (4488) 4488
medical research (4449) 4449
mice (4356) 4356
fluoxetine (4315) 4315
depressive disorder - drug therapy (4240) 4240
brain (4049) 4049
antidepressive agents - pharmacology (4026) 4026
double-blind (3840) 3840
depression - drug therapy (3836) 3836
antidepressants, tricyclic (3821) 3821
health aspects (3811) 3811
studies (3785) 3785
risk factors (3757) 3757
mental health (3720) 3720
pharmaceutical industry (3685) 3685
anxiety (3636) 3636
depressive disorder, major - drug therapy (3534) 3534
adolescent (3506) 3506
drug dosages (3335) 3335
medicine, experimental (3329) 3329
clinical trials (3327) 3327
bipolar disorder (3289) 3289
dose-response relationship, drug (2903) 2903
serotonin uptake inhibitors (2812) 2812
antidepressant drugs (2805) 2805
tricyclic antidepressants (2794) 2794
psychotropic drugs (2783) 2783
serotonin uptake inhibitors - therapeutic use (2782) 2782
mental disorders (2727) 2727
antidepressive agents - adverse effects (2666) 2666
serotonin reuptake inhibitors (2641) 2641
patients (2577) 2577
pharmacology (2524) 2524
usage (2464) 2464
dosage and administration (2435) 2435
stress (2418) 2418
abridged index medicus (2410) 2410
efficacy (2375) 2375
young adult (2323) 2323
time factors (2238) 2238
double-blind method (2217) 2217
article (2209) 2209
rats, sprague-dawley (2135) 2135
psychiatric status rating scales (2089) 2089
psychotherapy (2072) 2072
disease models, animal (2071) 2071
prescription drugs (2068) 2068
antidepressant treatment (2065) 2065
confidence intervals (2061) 2061
universities and colleges (2060) 2060
medicine, general & internal (2058) 2058
schizophrenia (2009) 2009
pain (2008) 2008
comorbidity (1966) 1966
metaanalysis (1964) 1964
behavior (1938) 1938
risk (1894) 1894
neurology (1893) 1893
pregnancy (1890) 1890
prevalence (1881) 1881
imipramine (1859) 1859
medicine & public health (1843) 1843
complications and side effects (1840) 1840
antipsychotic drugs (1834) 1834
psychopharmacology (1834) 1834
medicine (1791) 1791
physiological aspects (1756) 1756
behavior, animal - drug effects (1751) 1751
psychology (1739) 1739
paroxetine (1717) 1717
suicides & suicide attempts (1717) 1717
rodents (1696) 1696
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (92) 92
Online Resources - Online (21) 21
Collection Dvlpm't (Acquisitions) - Vendor file (15) 15
Collection Dvlpm't (Acquisitions) - Closed Orders (10) 10
UofT at Mississauga - Stacks (8) 8
UofT at Scarborough - Stacks (7) 7
St. Michael's College (John M. Kelly) - 2nd Floor (6) 6
Media Commons - Audio Visual (4) 4
UTL at Downsview - May be requested (4) 4
Gerstein Science - Periodical Stacks (3) 3
Robarts - Stacks (3) 3
Lakeridge Health Sciences - Oshawa (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (2) 2
University College (Laidlaw) - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Cancelled Order (1) 1
Gerstein Science - Circulation Desk (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Online (1) 1
Toronto East General Hospital - Chaplain Dept. (1) 1
UofT Schools - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (77438) 77438
French (977) 977
German (441) 441
Spanish (129) 129
Russian (81) 81
Japanese (64) 64
Portuguese (60) 60
Italian (56) 56
Turkish (39) 39
Polish (36) 36
Chinese (25) 25
Korean (18) 18
Czech (11) 11
Croatian (10) 10
Slovenian (7) 7
Swedish (5) 5
Danish (4) 4
Dutch (3) 3
Icelandic (3) 3
Persian (3) 3
Lithuanian (2) 2
Afrikaans (1) 1
Hungarian (1) 1
Indonesian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. The emperor's new drugs
: exploding the antidepressant myth
by Kirsch, Irving
2010, ISBN 9780465022007, xiv, 226
Kirsch, a researcher and clinical psychologist, for years referred patients to psychiatrists to treat their depression with drugs before deciding to... 
Psychotropic drugs | Depression | Effectiveness | drug therapy | Antidepressants | Therapeutic use
Book
Details down arrow
2. The myth of the chemical cure
: a critique of psychiatric drug treatment
by Moncrieff, Joanna, 1966
2008, ISBN 9780230574311, xi, 278
This book overturns the idea that psychiatric drugs work by correcting chemical imbalance and analyzes the professional, commercial and political vested... 
Psychotropic drugs | Evaluation | Chemotherapy | Mental illness | Psychopharmacology
Book
Details down arrow
3. Full Text Suicidality and risk of suicide - Definition, drug safety concerns, and a necessary target for drug development: A brief report
by Meyer, Roger E and Salzman, Carl and Youngstrom, Eric A and Clayton, Paula J and Goodwin, Frederick K and Mann, J. John and Alphs, Larry D and Broich, Karl and Goodman, Wayne K and Greden, John F and Meltzer, Herbert Y and Normand, Sharon-Lise T and Posner, Kelly and Shaffer, David and Oquendo, Maria A and Stanley, Barbara and Trivedi, Madhukar H and Turecki, Gustavo and Beasley Jr, Charles M and Beautrais, Annette L and Bridge, Jeffrey A and Brown, Gregory K and Revicki, Dennis A and Ryan, Neal D and Sheehan, David V
Journal of Clinical Psychiatry, ISSN 0160-6689, 08/2010, Volume 71, Issue 8, pp. 1040 - 1046
Objective: To address issues concerning potential treatment-emergent "suicidality," a consensus conference was convened March 23-24, 2009. Participants: This... 
YOUTH SUICIDE | UNITED-STATES | TRIALS | PSYCHIATRY | BEHAVIOR | ADOLESCENTS | PREVENTION | ADULTS | POLYUNSATURATED FATTY-ACIDS | ANTIDEPRESSANT MEDICATION | PSYCHOLOGY, CLINICAL | ASSOCIATION | Meta-Analysis as Topic | United States | Humans | Middle Aged | Risk Factors | Suicide - prevention & control | Serotonin Uptake Inhibitors - adverse effects | Terminology as Topic | Consensus Development Conferences as Topic | Suicide - statistics & numerical data | Cause of Death | Mental Disorders - psychology | Mental Disorders - drug therapy | Drug-Related Side Effects and Adverse Reactions | Adolescent | Suicide - psychology | Adult | Antidepressive Agents - adverse effects | Child | Mental Disorders - mortality | United States Food and Drug Administration | Drug Discovery - statistics & numerical data | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Side effects
: a prosecutor, a whistleblower, and a bestselling antidepressant on trial
by Bass, Alison
2008, 1st ed., ix, 260
Drugs | Paroxetine | Side effects | Antidepressants | GlaxoSmithKline Trials, litigation, etc | Spitzer, Eliot Trials, litigation, etc | Products liability
Book
Details down arrow
5. Framing drug use
: bodies, space, economy and crime
by Fitzgerald, John L. 1966- (John Lawrence)
2015, ISBN 9781137482235, xii, 289 pages
Framing Drug Use examines the forces that shape the way we use drugs. The book analyses space, streetscapes, languages, signs, photographs, stories, routines,... 
Psychological aspects | Social aspects | Drug abuse | Social sciences-Philosophy | Substance abuse
Book
Details down arrow
6. Full Text Do psychoactive drugs have a therapeutic role in compulsivity? Studies on schedule-induced polydipsia
by Martín-González, Elena and Prados-Pardo, Ángeles and Mora, Santiago and Flores, Pilar and Moreno, Margarita
Psychopharmacology, ISSN 0033-3158, 2/2018, Volume 235, Issue 2, pp. 419 - 432
Clinical studies have shown that some psychoactive recreational drugs have therapeutic applications in anxiety, depression, and schizophrenia. However, to... 
Compulsivity | Neurosciences | Biomedicine | Psychedelic drugs | Psychoactive drugs | Pharmacology/Toxicology | Psychiatry | Schedule-induced polydipsia | PSYCHIATRIC-PATIENTS | POSTTRAUMATIC-STRESS-DISORDER | ANTIDEPRESSANT-LIKE | MARBLE-BURYING BEHAVIOR | PSYCHIATRY | D-ASPARTATE ANTAGONIST | NEUROSCIENCES | PITUITARY-ADRENAL ACTIVITY | TRAUMATIC BRAIN-INJURY | PHARMACOLOGY & PHARMACY | ANIMAL-MODEL | MAJOR DEPRESSIVE DISORDER | LOW-DOSE METHAMPHETAMINE | Compulsive Behavior - psychology | Rats, Wistar | Drinking - physiology | Rats | Male | Polydipsia, Psychogenic - drug therapy | Polydipsia, Psychogenic - psychology | Psychotropic Drugs - therapeutic use | Dose-Response Relationship, Drug | Reinforcement Schedule | Animals | Compulsive Behavior - drug therapy | Psychotropic Drugs - pharmacology | Drinking Behavior - drug effects | Drinking - drug effects | Drinking Behavior - physiology | Compulsive behavior | Control | Care and treatment | Dosage and administration | Drinking of alcoholic beverages | Methamphetamine | Drugs | Drug addiction | Drug abuse | Scopolamine | Mental disorders | Therapeutic applications | Disorders | Schizophrenia | Mental depression | Drug development | Psychotropic drugs | Ketamine | Methamphetamines | Psychopharmacology | Anxiety | Drug dosages | Polydipsia | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Drug–drug interaction and doping: Effect of non‐prohibited drugs on the urinary excretion profile of methandienone
by Mazzarino, Monica and Khevenhüller‐Metsch, Franziska L and Fiacco, Ilaria and Parr, Maria Kristina and Torre, Xavier and Botrè, Francesco
Drug Testing and Analysis, ISSN 1942-7603, 10/2018, Volume 10, Issue 10, pp. 1554 - 1565
The potential consequences of drug–drug interactions on the excretion profile of the anabolic androgenic steroid methandienone... 
antidepressants | methandienone | antifungals | drug–drug interaction | anti‐doping analysis | anti-doping analysis | VITRO | CHEMISTRY, ANALYTICAL | I METABOLIC PROFILE | BIOCHEMICAL RESEARCH METHODS | HUMANS | STANOZOLOL | TOREMIFENE | MASS-SPECTROMETRIC IDENTIFICATION | ANABOLIC-STEROIDS | CYTOCHROME-P450 ENZYMES | KETOCONAZOLE | PHARMACOLOGY & PHARMACY | drug-drug interaction | METANDIENONE | Antifungal Agents - pharmacology | Substance Abuse Detection - methods | Antifungal Agents - urine | Ketoconazole - administration & dosage | Methandrostenolone - urine | Humans | Middle Aged | Methandrostenolone - administration & dosage | Urinalysis - methods | Ketoconazole - pharmacology | Methandrostenolone - metabolism | Drug Interactions | Anabolic Agents - administration & dosage | Metabolome - drug effects | Anabolic Agents - urine | Metabolic Networks and Pathways - drug effects | Chromatography, Liquid - methods | Antifungal Agents - administration & dosage | Ketoconazole - urine | Tandem Mass Spectrometry - methods | Anabolic Agents - metabolism | Physiological aspects | Complications and side effects | Antidepressants | Mass spectrometry | Drug interactions | Analysis | Drugs & sports | Metabolites | Metabolism | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Drug Treatment in Older People before and after the Transition to a Multi-Dose Drug Dispensing System-A Longitudinal Analysis
by Wallerstedt, Susanna M and Fastbom, Johan and Johnell, Kristina and Sjöberg, Christina and Landahl, Sten and Sundström, Anders and Stockholms universitet and Centrum för forskning om äldre och åldrande (ARC), (tills m KI) and Samhällsvetenskapliga fakulteten
PLoS ONE, ISSN 1932-6203, 06/2013, Volume 8, Issue 6, pp. e67088 - e67088
Background: An association has been found between multi-dose drug dispensing (MDD) and use of many drugs. The aim of this study was to investigate the nature... 
QUALITY | DEMENTIA | PRESCRIPTION | MEDICATION ERRORS | MULTIDISCIPLINARY SCIENCES | NURSING-HOMES | HEALTH-CARE | ELDERLY-PATIENTS | Dose-Response Relationship, Drug | Sweden | Humans | Aged, 80 and over | Female | Male | Aged | Practice Patterns, Physicians | Drug Prescriptions | Longitudinal Studies | Drugs | Prescribing | Dispensing | Usage | Analysis | Health care | Nursing homes | Substance abuse treatment | Statistical analysis | Regression analysis | Confidence limits | Studies | Prescription drugs | Hospitals | Medical errors | Older people | Pharmacy | Population | Identity | Drug dosages | Elderly | Inhabitants | Dementia | Geriatrics | Index Medicus | Basic Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Physicians | Public Health, Global Health, Social Medicine and Epidemiology | Antidepressant drug therapy | Hälsovetenskaper | Drug delivery | Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi | Drug safety | Antipsychotics | Medicinska och farmaceutiska grundvetenskaper | Farmakologi och toxikologi | Pharmacology and Toxicology | Drug therapy | Public and occupational health | Health Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Mesoporous hydroxyapatite as a carrier of olanzapine for long-acting antidepression treatment in rats with induced depression
by Shyong, Yan-Jye and Wang, Mao-Hsien and Kuo, Wei-Ting and Kuo, Li-Wei and Su, Chang-Fu and Chang, Kuo-Chi and Lin, Feng-Huei
Journal of Controlled Release, ISSN 0168-3659, 06/2017, Volume 255, pp. 62 - 72
An antidepressant carrier, mesoporous hydroxyapatite olanzapine (mesoHAP-OLZ), was designed to maintain 3 weeks of constant medication release. The carrier was... 
Learning and memory abilities | Hydroxyapatite | Prolong antidepressant drug carrier | Serotonin | Locomotor activities | BEHAVIOR | MORRIS WATER MAZE | CHRONIC MILD STRESS | SCOPOLAMINE | MODEL | CHEMISTRY, MULTIDISCIPLINARY | HIPPOCAMPAL VOLUME | NANOPARTICLES | MEMORY | MOOD DISORDERS | PHARMACOLOGY & PHARMACY | MICE | Drug Carriers - therapeutic use | Rats, Wistar | Drug Carriers - administration & dosage | Drug Carriers - toxicity | Male | Drug Carriers - chemistry | Brain - metabolism | Depression - drug therapy | Depression - metabolism | Durapatite - administration & dosage | Behavior, Animal - drug effects | Locomotion - drug effects | Durapatite - toxicity | Serotonin Uptake Inhibitors - toxicity | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - chemistry | Durapatite - chemistry | Maze Learning - drug effects | Brain - drug effects | Animals | Benzodiazepines - toxicity | Serotonin Uptake Inhibitors - administration & dosage | Serotonin - metabolism | Benzodiazepines - chemistry | Drug Liberation | Benzodiazepines - administration & dosage | Durapatite - therapeutic use | Porosity | Benzodiazepines - therapeutic use | Antidepressants | Depression, Mental | Olanzapine | Drugs | Drug delivery systems | Research institutes | Vehicles | Biomedical engineering | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Use of fall-risk inducing drugs in patients using anti-Parkinson drugs (APD): A Swedish register-based study
by Haasum, Ylva and Fastbom, Johan and Johnell, Kristina and Stockholms universitet and Centrum för forskning om äldre och åldrande (ARC), (tills m KI) and Samhällsvetenskapliga fakulteten
PLoS ONE, ISSN 1932-6203, 08/2016, Volume 11, Issue 8, pp. e0161246 - e0161246
Objectives Many drugs increase the risk of falls in old age. Although persons with Parkinson's disease (PD) are at increased risk of experiencing falls and... 
INCREASING DRUGS | HIP FRACTURE | OLDER-PEOPLE | METAANALYSIS | MULTIDISCIPLINARY SCIENCES | NONMOTOR SYMPTOMS | DISEASE | POPULATION-BASED COHORT | ELDERLY-PEOPLE | PREVALENCE | MEDICATION USE | Humans | Accidental Falls - statistics & numerical data | Female | Logistic Models | Male | Registries | Aged | Sweden - epidemiology | Antiparkinson Agents - adverse effects | Case-Control Studies | Risk Management | Control | Care and treatment | Falls (Accidents) | Influence | Aged patients | Research | Health aspects | Antiparkinsonian agents | Drugs | Drug abuse | Neurosciences | Parkinson's disease | Neurobiology | Parkinsons disease | Risk | Systematic review | Epidemiology | Psychotropic drugs | Polypharmacy | Antidepressants | Older people | Aging | Population | Movement disorders | Nursing homes | Neurodegenerative diseases | Narcotics | Health risks | Data processing | Hospitalization | Housing | Patients | Falls | Studies | Prescription drugs | Fractures | Society | Index Medicus | Annan naturvetenskap | Naturvetenskap | Natural Sciences | Other Natural Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Common Drug Side Effects and Drug‐Drug Interactions in Elderly Adults in Primary Care
by Merel, Susan E and Paauw, Douglas S
Journal of the American Geriatrics Society, ISSN 0002-8614, 07/2017, Volume 65, Issue 7, pp. 1578 - 1585
Prescribing medications, recognizing and managing medication side effects and drug interactions, and avoiding polypharmacy are all essential skills in the care... 
medication use | drug‐drug interactions | polypharmacy | drug-drug interactions | PATIENTS RECEIVING INHIBITORS | VITAMIN-D | METAANALYSIS | MANAGEMENT | OLDER-ADULTS | PROTON PUMP INHIBITORS | RISK | STATINS | GERIATRICS & GERONTOLOGY | HYPONATREMIA | GERONTOLOGY | MYALGIA | Primary Health Care - methods | Drug Interactions | Practice Patterns, Physicians' - standards | Prescription Drugs - therapeutic use | Drug-Related Side Effects and Adverse Reactions | Humans | Aged | Complications and side effects | Anticoagulants (Medicine) | Drug interactions | Warfarin | Peptidase | Calcium | Trimethoprim | Serotonin uptake inhibitors | Primary care | Nonsteroidal antiinflammatory drugs | Trimethoprim-sulfamethoxazole | Prescription drugs | Sulfamethoxazole | Side effects | Reviews | Antibiotics | Antidepressants | Older people | Zolpidem | Statins | Geriatrics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Drug-drug interactions and clinical considerations with co-administration of antiretrovirals and psychotropic drugs
by Goodlet, Kellie J and Zmarlicka, Monika T and Peckham, Alyssa M
CNS Spectrums, ISSN 1092-8529, 2018, Volume 24, Issue 3, pp. 1 - 26
Psychotropic medications are frequently co-prescribed with antiretroviral therapy (ART), owing to a high prevalence of psychiatric illness within the... 
drug interactions | HIV | antiretroviral therapy | anxiolytics | antipsychotics | AIDS | antidepressants | ATTENTION-DEFICIT-HYPERACTIVITY | VIRUS-INFECTED PATIENTS | PSYCHIATRY | BUPROPION PLASMA-CONCENTRATIONS | CLINICAL NEUROLOGY | SINGLE-DOSE NEVIRAPINE | TENOFOVIR DISOPROXIL FUMARATE | PATIENTS RECEIVING NEVIRAPINE | HIV-POSITIVE PATIENTS | ST-JOHNS-WORT | PLACEBO-CONTROLLED TRIAL | TO-CHILD TRANSMISSION
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Chronic Social Stress Inhibits Cell Proliferation in the Adult Medial Prefrontal Cortex: Hemispheric Asymmetry and Reversal by Fluoxetine Treatment
by Czéh, Boldizsár and Müller-Keuker, Jeanine I.H and Rygula, Rafal and Abumaria, Nashat and Hiemke, Christoph and Domenici, Enrico and Fuchs, Eberhard
Neuropsychopharmacology, ISSN 0893-133X, 07/2007, Volume 32, Issue 7, pp. 1490 - 1503
Profound neuroplastic changes have been demonstrated in various limbic structures after chronic stress exposure and antidepressant treatment in animal models... 
NG2 | Stereology | Glia | Cell number | Neurogenesis | Hippocampus | hippocampus | CHRONIC PSYCHOSOCIAL STRESS | PSYCHIATRY | stereology | ANTIDEPRESSANT TREATMENT | glia | NEUROSCIENCES | cell number | NEURONAL SIZE | ELECTROCONVULSIVE SEIZURES | TRANSCRANIAL MAGNETIC STIMULATION | MOOD DISORDERS | neurogenesis | PHARMACOLOGY & PHARMACY | RAT HIPPOCAMPUS | MAJOR DEPRESSIVE DISORDER | HIPPOCAMPAL NEUROGENESIS | LIFE EVENTS | Rats, Wistar | Cell Count | Prefrontal Cortex - physiopathology | Body Weight - drug effects | Bromodeoxyuridine | Depressive Disorder - drug therapy | Male | Stem Cells - metabolism | Dentate Gyrus - physiopathology | Neuroglia - drug effects | Prefrontal Cortex - pathology | Prefrontal Cortex - drug effects | Dentate Gyrus - drug effects | Social Behavior | Functional Laterality - drug effects | Functional Laterality - physiology | Neurons - metabolism | Neurons - drug effects | Cell Differentiation - physiology | Cell Survival - physiology | Cell Survival - drug effects | Fluoxetine - pharmacology | Stress, Psychological - drug therapy | Rats | Organ Size - physiology | Organ Size - drug effects | Animals | Cell Differentiation - drug effects | Depressive Disorder - physiopathology | Stem Cells - drug effects | Neuroglia - metabolism | Cell Proliferation - drug effects | Body Weight - physiology | Serotonin Uptake Inhibitors - pharmacology | Chronic Disease | Stress, Psychological - physiopathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights